Graduate StudentLOYOLA UNIVERSITY OF CHICAGOChicago, IL, United States
Disclosure information not submitted.
SAT-289 - Development of Thienopyrimidine-Based Selective Estrogen Receptor Degraders for Breast Cancer
Saturday, June 13, 20269:30 AM - 4:30 PM CT